MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    The Impact of Vocal Fold Augmentation with Injection Laryngoplasty on Voice Quality in Patients with Parkinson Disease

    O. Klepitskaya, J. Barr, Y. Liu, S. Sillau, J. Litts, D. Fink, M. Shaffer, J. Newcombe, A. Klepitskaya, M. Clary (Aurora, CO, USA)

    Objective: To evaluate the effect of vocal fold injection augmentation with a temporary filler (carboxymethylcellulose gel) on voice and speech in Parkinson Disease (PD) patients…
  • 2018 International Congress

    A multimodal motor skill balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease

    T. Capato, J. Nonnekes, J. Tornai, I. Kayo, J. IntHout, E. Barbosa, N. de Vries, M. Piemonte, B. Bloem (Sāo Paulo, Brazil)

    Objective: To study the effectiveness of Multimodal Motor Skill Balance Training (MBT) with rhythmical auditory cues to improve balance control and reduce falls in PD.…
  • 2018 International Congress

    A Computer-Aided Prescription Model for Parkinson’s Disease could predict the suitable drugs for Parkinson’s disease (PD) patients

    Y. Pan, L. Zhang (Nanjing, China)

    Objective: Using machine learning techniques to automatically recommend suitable drugs for Parkinson’s Disease (PD) patients, thereby providing computer-aided prescriptions. Background: PD is the second most…
  • 2018 International Congress

    DIRECT DBS: A Prospective, Multicenter Clinical Study with Double-Blinding for a Directional Deep Brain Stimulation Lead – Therapeutic Windows with Directional Stimulation

    F. Steigerwald, J. Volkmann, C. Matthies, A. Dalal Kirsch, S. Chabardes, R. de Bie, P. Schuurman, E. Moro, V. Fraix, S. Meoni, D. Blum, L. Juarez Paz, K. Wynants, N. Van Dyck (Würzburg, Germany)

    Objective: To evaluate changes in therapeutic window values for changes in directional Deep Brain Stimulation (DBS) stimulation. Background: Historically, DBS systems have delivered stimulation using…
  • 2018 International Congress

    Clinical trial protocol: Restitution of oral transport, penetration and aspiration with nigral stimulation in Parkinson’s disease?

    A. Schoellmann, L. Stoll, B. Hobl, C. Meisner, A. Gharabaghi, D. (Tuebingen, Germany)

    Objective: In this randomized controlled clinical trial, we aim to characterize the differential effect of subthalamic nucleus (STN) or subthalamic nucleus and substantia nigra pars…
  • 2018 International Congress

    Patient and Provider Experiences and Attitudes toward Rytary

    S. Horn, D. Coughlin, J. Chou, F. Wang, M. Stacy, R. Dolhun, C. Kopil, N. Amondikar, A. Deik, H. Sarva (Philadelphia, PA, USA)

    Objective: To survey Parkinson’s disease (PD) patients and providers about their experiences using Rytary, an oral extended release carbidopa/levodopa capsule (ER C/L). Background: ER C/L…
  • 2018 International Congress

    Double-blind controlled trial of Spectramax™ light therapy for the treatment of Parkinson’s disease patients on stable dopaminergic therapy

    A. Videnovic, S. Rutten, W. Croft, H. Erickson, J. Groves, C. Havemann, T. Herrington, S. Hendrix, K. Kieburtz, Y. vander Werf, O. vanden Heuvel (Boston, MA, USA)

    Objective: To evaluate the safety and effectiveness of Spectramax™ specialized bandwidth light therapy (LT) as adjunctive treatment in Parkinson’s disease (PD). Background: Previous studies have…
  • 2018 International Congress

    Distance to white matter tracts predicts STN deep brain stimulation outcome of tremor and dysarthria in Parkinson’s disease

    L. Boon, N. Prent, W. Potters, M. Caan, H. Berendse, R. de Bie, P. vd Munckhof, P. Schuurman, A. van Rootselaar (Amsterdam, Netherlands)

    Objective: To establish the association between the distance of subthalamic nucleus (STN) deep brain stimulation (DBS) electrode contact points to relevant white matter tracts and…
  • 2018 International Congress

    Is lowering stimulation frequency a feasible option to improve speech in Parkinson’s disease patients undergoing subthalamic deep brain stimulation?

    M. Fabbri, M. Zibetti, G. Ferrero, A. Accornero, I. Guimaraes, M. Rizzone, A. Romagnolo, J. Ferreira, L. Lopiano (Lisbon, Portugal)

    Objective: To analyzse the effect of low frequency (LFS) subthalamic nucleus deep brain stimulation (STN-DBS) on speech and voice in Parkinson’s disease (PD) patients with…
  • 2018 International Congress

    A 15-year review of a movement disorder database in Singapore

    A. Wong, S. Neo, H.L. Ng, W. Li, K.Y. Tay, W.L. Au, L. Tan (Singapore, Singapore)

    Objective: To establish the prevalence and demographical characteristics of patients seen in a Movement Disorders (MD) Centre. Background: Movement disorders contribute to a significant proportion…
  • « Previous Page
  • 1
  • …
  • 239
  • 240
  • 241
  • 242
  • 243
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley